ERBB2 and triple-negative breast carcinoma: In particular, the treatment of some kind of triple negative breast cancer (TNBC) -so called because the cancer cells lack receptor for estrogen (ER−) and progesterone (PR−) and do not express the human epidermal growth factor receptor 2 (HER2−)- is quite complex because to an initial response follows a resistance to therapy [3].